Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer

Sun, Y; Peng, WF; He, WW; Luo, M; Chang, GL; Shen, JP; Zhao, XP; Hu, Y

Hu, Y (reprint author), Fudan Univ, Zhongshan Hosp, Dept Geriatr, Shanghai 200032, Peoples R China.; Zhao, XP (reprint author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Nucl Med, Shanghai 200025, Peoples R China.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018; 37 ():

Abstract

Background: The KRAS mutation is the driving force of pancreatic ductal adenocarcinoma (PDAC). Downstream effectors of KRAS signal pathways are crucia......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索